Dr Fried man cor rectly draws our at tention to the long-term de vel op men tal effects of se lec tive se ro to nin reuptake in hib i tors (SSRIs) on breast-fed in fants (1). As Dr Misri ob serves at the end of her ar ti cle, these ef fects "re main unknown" (2). Dr Misri, how ever, re views the rel a tive safety of these com pounds on fe tal and early in fant de vel op ment. As she notes, the dan gers of no treat ment for moth ers with de pres sion in clude mater nal sui cide, im pair ments in the mother-child re la tion ship (as il lus trated in my let ter [3] ) and break down of the spousal re la tion ship. Long-term risks to the fe tus, in clud ing de layed mo tor devel op ment, re duced growth, and a lower IQ, com pared with in fants whose mothers were suc cess fully treated for de pression, are also well re viewed by Dr Misri. Up-to-date in for ma tion to help pa tients eval u ate risks ver sus ben e fits are now avail able through such re sources as Mother Risk at the Hos pi tal for Sick Children in To ronto (416-813-6780; www.motherisk. org).
While Dr Fried man's an i mal data are inter est ing, they are not con vinc ing as scien tific ev i dence of proven risk in hu mans. Dear Ed i tor:
Ref er ences
The term "rapid-cy cling" was ini tially used to de note a vari ant of bi po lar ill ness with 4 or more ep i sodes yearly and a poor re sponse to lith ium (1). In some patients, rapid cy cling is as so ci ated with the use of an ti de pres sant drugs (2). An tide pres sant use, how ever, may be unavoid able for pa tients who ex pe ri ence per sis tent de pres sion de spite treat ment with mood sta bi liz ers. The treat ment of rapid cy cling can thus be chal leng ing in pa tients who have a con cur rent phys i cal dis or der, such as fibromyalgia, in which an ti de pres sants are the main stay of pharma co log i cal treat ment (3). We de scribe such a case, wherein the use of tryptophan in a low dose no ta bly improved symp toms of fibromyalgia and also re sulted in a sus tained mood sta bi li za tion.
Case Re port
Ms A is a 40-year-old lady who has presented with a his tory of re cur rent ep isodes of de pres sion since her mid-teens. The de pres sive ep i sodes have var ied in du ra tion be tween 2 days and 3 months, and have been char ac ter ized by symptoms of sad mood, anhedonia, poor concen tra tion, lack of en ergy, and amotivation. She has a his tory of hypomanic spells, which she has described as "binges," char ac ter ized by expan sive mood, in clud ing over ac tivi ty, de creased re quire ment for sleep, ex cessive spend ing of money, con sump tion of large quan ti ties of al co hol, and the use of street drugs. She also has a his tory of polysubstance abuse from ad o les cence un til her early twen ties. Physically, she has suf fered from fibromyalgia, with symp toms of dif fuse myalgia, fa tigue, de creased pain thresh old, lo cal ized areas of ten der ness, and nonrestorative sleep. Fam ily his tory re vealed that her fa ther suf fered from de pres sion, her mother from fibromyalgia and de pression, and that a brother had bi po lar dis order. The mood dis or der was se vere enough to in ter fere with her level of func tion ing; she had been un able to run her daycare cen tre for sev eral years.
Ms A had tried var i ous an ti de pres sant drugs, in clud ing sertraline 250 mg, fluoxetine 20 mg, amitriptyline 150 mg, and clomipramine 200 mg daily. An ti depres sants were ei ther in ef fec tive or resulted in ac cel er ated cy cle fre quency and in duced hypomania. Sim i larly, mood sta bi liz ers such as lith ium 1200 mg, divalproex so dium 1250 mg, and carbamazepine 600 mg daily, used alone or in com bi na tion, were in ef fec tive. The mood sta bi liz ers com bined with an ti depres sants led to in creased cy cle frequency. She ques tioned the ef fec tive ness of var i ous treat ment in terven tions and be came in creas ingly frustrated with her on go ing mood in sta bil ity, chronic pain con di tion, and poor psychosocial func tion ing. At this time, it was de cided to pre scribe a trial of tryptophan. The dos age was grad u ally in creased over a cou ple of weeks to 4 g daily. She re mained on lorazepam 1 mg and oxazepam 25 mg daily, which she had taken for sev eral years. Within 2 weeks of reach ing the 4 g dos age, she devel oped a mixed state char ac ter ized by symp toms of feel ing "revved up," ir ri table, ag i tated, with rac ing thoughts, preoc cu pa tion with thoughts of sui cide, and dysphoria. The tryptophan dos age was grad u ally low ered to 2 g, and her mood has been quite sta ble for at least 18 months. She con tin ues to ex pe ri ence symp toms of fibromyalgia, but these are not as in tense or dis abling as be fore. She has been gain fully em ployed for more than 1 year and re mains on the drug reg imen of tryptophan 2 g, lorazepam 1 mg, and oxazepam 25 mg daily.
